Skip to main content
. 2022 Feb 17;12:2763. doi: 10.1038/s41598-022-06663-0

Table 2.

Discriminative measures for the Stockholm cohort.

Sensitivity Specificity PPV NPV
PD 84% (21/25) 100% (10/10) 100% (21/21) 71.4% (10/14)
APS 80% (8/10) 100% (25/25) 100% (8/8) 93% (25/27)
MSA 50% (2/4) 100% (4/4) 100% (2/2) 67% (4/6)
PSP 50% (2/4) 100% (4/4) 100% (2/2) 67% (4/6)

APS atypical parkinsonian syndrome, MSA multiple system atrophy, NPV negative predictive value, PD Parkinson’s disease, PPV positive predictive value, PSP progressive supranuclear palsy.